ProGreen Properties (OTCMKTS:PGUS – Get Free Report) and Hyperion DeFi (NASDAQ:HYPD – Get Free Report) are both finance companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, risk, valuation, dividends, profitability, analyst recommendations and institutional ownership.
Profitability
This table compares ProGreen Properties and Hyperion DeFi’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| ProGreen Properties | N/A | N/A | N/A |
| Hyperion DeFi | 416.56% | -13.93% | -11.60% |
Analyst Recommendations
This is a breakdown of current ratings and price targets for ProGreen Properties and Hyperion DeFi, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| ProGreen Properties | 0 | 0 | 0 | 0 | 0.00 |
| Hyperion DeFi | 2 | 0 | 2 | 0 | 2.00 |
Valuation & Earnings
This table compares ProGreen Properties and Hyperion DeFi”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| ProGreen Properties | N/A | N/A | N/A | N/A | N/A |
| Hyperion DeFi | $810,000.00 | 50.91 | -$45.31 million | ($6.53) | -0.42 |
ProGreen Properties has higher earnings, but lower revenue than Hyperion DeFi.
Institutional & Insider Ownership
25.8% of Hyperion DeFi shares are owned by institutional investors. 4.3% of ProGreen Properties shares are owned by insiders. Comparatively, 7.5% of Hyperion DeFi shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Summary
Hyperion DeFi beats ProGreen Properties on 7 of the 9 factors compared between the two stocks.
About ProGreen Properties
ProGreen US, Inc., together with its subsidiaries, focuses on agricultural operations and residential real estate development activities in Baja California, Mexico. The company was formerly known as ProGreen Properties, Inc. and changed its name to ProGreen US, Inc. in July 2016. ProGreen US, Inc. was founded in 1982 and is based in San Diego, California.
About Hyperion DeFi
Eyenovia, Inc., an ophthalmic technology company, engages in the development of therapeutics based on its proprietary microdose array print platform technology. The company's product candidates include MicroPine, which is in Phase III clinical development program with indications for pediatric myopia progression (near-sightedness); MicroLine, which is in Phase III clinical development program with indications for the improvement in near vision in people with presbyopia; and Mydcombi, which is in Phase III clinical development program with indications for pharmaceutical mydriasis. It has a license agreement with Bausch Health Ireland Limited to develop and commercialize MicroPine in the United States and Canada; a license agreement with Arctic Vision (Hong Kong) Limited to develop and commercialize MicroPine, MicroLine, and Mydcombi in China and South Korea; and Senju Pharmaceutical Co., Ltd. to develop and commercialize MicroPine, MicroLine, and Mydcombi. The company was formerly known as PGP Holdings V, Inc. and changed its name to Eyenovia, Inc. in May 2014. Eyenovia, Inc. was incorporated in 2014 and is based in New York, New York.
Receive News & Ratings for ProGreen Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProGreen Properties and related companies with MarketBeat.com's FREE daily email newsletter.
